Insulin sensitivity is an important factor in the management of diabetes, as it affects how well your body can use insulin to make glucose available to cells for energy. Improving insulin sensitivity is an important goal for people with diabetes, and researchers are continually looking for new ways to do …
Read More »The Role of Bisphenol A in the Risk for Developing Type 2 Diabetes
Bisphenol A (BPA) is an industrial chemical that is widely used in the production of plastic products and food packaging materials. Despite its widespread use, recent research has suggested that BPA exposure may be associated with an increased risk of developing type 2 diabetes. Type 2 diabetes is a chronic …
Read More »Older Adults Living with Type 2 Diabetes – Challenges and Solutions
Type 2 diabetes is a growing health concern among older adults, with an estimated 29 million individuals over the age of 65 in the United States alone being diagnosed with the condition. While type 2 diabetes can affect people of all ages, it is particularly prevalent among older adults due …
Read More »Diabetes in Control’s Top 5 Most Popular Articles from 2022
Now that 2022 is behind us, Diabetes in Control presents our top 5 viewed articles from the year. Delve into this content to learn more about diabetes, its effects on individuals with the condition, and a revolutionary treatment breakthrough. #1 The impact of health coaching with family support on patient …
Read More »Tirzepatide: A Dual GLP-1/GIP Receptor Agonist for the Treatment of T2D
Authors: Ashley Wagnild, PharmD Candidate 2024, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 54-year-old man was referred to the pharmacotherapy clinic by his primary care provider (PCP) for a therapy consult. The patient had a past medical …
Read More »FDA Approves First Drug for Delaying Type 1 Diabetes – What You Should Know
Recently, the United States Food and Drug Administration granted approval for Tzield (teplizumab-mzwv) injection: a groundbreaking treatment intended to obstruct the progression of stage 2 type 1 diabetes into its more serious form in adults as well as pediatric patients who are 8 years or older. John Sharretts, M.D., director …
Read More »Bromocriptine-QR Therapy and its Impact on the Pro-inflammatory State of Type 2 Diabetes Subjects in Relation to CVD
Sponsored Content Bromocriptine-QR (Cycloset) “is a sympatholytic dopamine D2 agonist for the treatment of type 2 diabetes that has demonstrated rapid (within 1 year) substantial reductions in adverse cardiovascular events in this population by as yet incompletely delineated mechanisms.” This study investigated the impact of Cycloset on the pro-inflammatory state …
Read More »Gestational Diabetes: One-Step or Two-Step Screening
No specific approach is used currently but which one is better? Every year, 2% to 10% of pregnant women are diagnosed with gestational diabetes. Gestational diabetes is a type of diabetes that develops in pregnant women who did not have diabetes before they got pregnant. Some causes or risk factors …
Read More »Could Dapagliflozin Be Beneficial in The Treatment of Patients with Type 2 Diabetes and Multiple Risk Factors
What are the effects of prescribing sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and multiple risk factors? Type 2 diabetes (T2D) usually occurs with multiple risk factors and complications. When treating patients with T2D targeting several risk factors, especially in the early stages of the disease state, …
Read More »Researchers Identify Issues Facing Older Adults Living with Diabetes
The diabetic UK teams developed eight priority questions and recommendations to improve the quality of life and care of older diabetic patients. Older adults living with diabetes are on the rise, and geriatricians are constantly experiencing difficulties providing care for these patient populations. The challenges may stem from the fact …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.